PLEASE NOTE:  The purpose of this webpage is to educate and inform healthcare professionals about Little Green Pharma products. These products are not registered on the Australian Register of Therapeutic Goods (ARTG) and are currently only available by prescription approved under the Special Access Scheme (SAS) or issued by an Approved Prescriber.

Little Green Pharma has produced a range of Medical Cannabis Oil preparations with various cannabinoid profiles.

Our strictly controlled growing conditions and product testing, that conforms with Therapeutic Goods (Standard for Medicinal Cannabis) (TGO 93) Order 2017 standards, mean we produce a consistent, natural product, grown without pesticides.

Little Green Pharma can arrange the supply to doctors of the following products with an approved prescription obtained via Special Access Scheme or Authorised Prescriber applications.

LGP Classic Range

This product range is made from a whole plant (full spectrum) extract and adheres to strict testing to ensure a consistent product.

The LGP Classic range has a variety of THC and CBD ratios presented in a simple oil formulation. THC and CBD in a 1:1 ratio is a common starting point for Australian practitioners.

Little Green Pharma has implemented three colours to assist medical practitioners and patients identify the general category of cannabinoids in our products: THC-dominant, THC/CBD Balance (equal ratios of THC and CBD) and CBD-dominant. The THC dominant products are represented by orange, THC/CBD Balance by green and CBD dominant represented by blue.

LGP Classic 10:10

THC:10mg/mL
CBD:10mg/mL
50mL Oral Solution

LGP Classic 20:5

THC:20mg/mL
CBD:5mg/mL
50mL Oral Solution

LGP Classic 1:20

THC:1mg/mL
CBD:20mg/mL
50mL Oral Solution

Want to know more about our cannabis oil products?

For more information about these medical cannabis oil products please speak to your usual treating medical practitioner or pharmacist.

Medical Practitioners can contact our education team at medical@lgpharma.com.au or Ph (08) 6280 0050.

Patients can read how to access medical cannabis and speak to your doctor about this treatment option.